|
1
|
Peng Y, Dai Y, Hitchcock C, Yang X, Kassis
ES, Liu L, Luo Z, Sun HL, Cui R, Wei H, et al: Insulin growth
factor signaling is regulated by microRNA-486, an underexpressed
microRNA in lung cancer. Proc Natl Acad Sci USA. 110:15043–15058.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortettieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Zeng H and Zhang S:
Epidemiology of lung cancer in China. Thoracic Cancer. 6:2092015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Janssen-Heijnen ML and Coebergh JW: The
changing epidemiology of lung cancer in Europe. Lung Cancer.
41:245–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mahapatra A: Lung cancer-genomics and
personalized medicine. ACS Chem Biol. 5:529–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dumortier O and Van Obberghen E: MicroRNAs
in pancreas development. Diabetes Obes Metab. 14:(Suppl 3).
S22–S28. 2012. View Article : Google Scholar
|
|
8
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nana-Sinkam SP and Croce CM: Clinical
applications for microRNAs in cancer. Clin Pharmacol Ther.
93:98–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arner P and Kulyté A: MicroRNA regulatory
networks in human adipose tissue and obesity. Nat Rev Endocrinol.
11:276–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Patnaik SK, Yendamuri S, Kannisto E,
Kucharczuk JC, Singhal S and Vachani A: MicroRNA expression
profiles of whole blood in lung adenocarcinoma. Plos One.
7:e460452012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen J and Jiang F: Applications of
microRNAs in the diagnosis and prognosis of lung cancer. Expert
Opin Med Diagn. 6:197–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun D, Li X, Ma M, Liu J, Xu Y, Ye L, Hou
H, Wang C, Li X and Jiang Y: The predictive value and potential
mechanisms of miRNA-328 and miRNA-378 for brain metastases in
operable and advanced non-small-cell lung cancer. Jpn J Clin Oncol.
45:464–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: miRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu ZL, Wang H, Liu J and Wang ZX:
MicroRNA-21 (miR-21) expression promotes growth, metastasis and
chemo- or radioresistance in non-small cell lung cancer cells by
targeting PTEN. Mol Cell Biochem. 372:35–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao W, Wei W, Zhan Z, Xie Y and Xiao Q:
miR-1284 modulates multidrug resistance of gastric cancer cells by
targeting EIF4A1. Oncol Rep. 35:2583–2591. 2016.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fernandez S, Risolino M, Mandia N, Talotta
F, Soini Y, Incoronato M, Condorelli G, Banfi S and Verde P:
miR-340 inhibits tumor cell proliferation and induces apoptosis by
targeting multiple negative regulators of p27 in non-small cell
lung cancer. Oncogene. 34:3240–3250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chu I, Hengst L and Slingerland J: The Cdk
inhibitor p27 in human cancer: Prognostic potential and relevance
to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fuchs Y and Steller H: Programmed cell
death in animal development and disease. Cell. 147:742–758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mckenzie S and Kyprianou N: Apoptosis
evasion: The role of survival pathways in prostate cancer
progression and therapeutic resistance. J Cell Biochem. 97:18–32.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Green DR: Apoptotic pathways: Paper wraps
stone blunts scissors. Cell. 102:1–4. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pop C and Salvesen GS: Human caspases:
Activation, specificity, and regulation. J Biol Chem.
284:21777–217817. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brentnall M, Rodriguez-Menocal L, De
Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maurya SK, Tewari M, Sharma B and Shukla
HS: Expression of procaspase 3 and activated caspase 3 and its
relevance in hormone-responsive gallbladder carcinoma chemotherapy.
Korean J Intern Med. 28:573–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Youle R and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ding J, Mooers BH, Zhang Z, Kale J,
Falcone D, McNichol J, Huang B, Zhang XC, Xing C, Andrews DW and
Lin J: After embedding in membranes antiapoptotic Bcl-XL protein
binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax
protein to inhibit apoptotic mitochondrial permeabilization. J Biol
Chem. 289:11873–11896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Soucek L, Whitfield JR, Sodir NM,
Massó-Vallés D, Serrano E, Karnezis AN, Swigart LB and Evan GI:
Inhibition of Myc family proteins eradicates KRas-driven lung
cancer in mice. Genes Dev. 27:504–513. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meyer N, Kim SS and Penn LZ: The
Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol.
16:275–287. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Romero OA, Torres-Diz M, Pros E, Savola S,
Gomez A, Moran S, Saez C, Iwakawa R, Villanueva A, Montuenga LM, et
al: MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF
programs and is synthetic lethal with BRG1. Cancer Discov.
4:292–303. 2014. View Article : Google Scholar : PubMed/NCBI
|
